ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Consolidated sales rebates and discounts liability by Year
Consolidated sales rebates and discounts liability ($M) ($M)
Eli Lilly Consolidated sales rebates and discounts liability: $17,382M in FY2025, up 50.6% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Consolidated Balance Sheets.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated sales rebates and discounts liability ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17,382 | +50.6% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 11,539 | -1.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 11,689 | +33.1% | Form 10-K (filed 2025-02-19) ↗ |
| FY2022 | Dec 31, 2022 | 8,784 | +28.3% | Form 10-K (filed 2024-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 6,846 | +17.0% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 5,853 | +18.6% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 4,934 | +1.7% | Form 10-K (filed 2021-02-17) ↗ |
| FY2018 | Dec 31, 2018 | 4,850 | +8.6% | Form 10-K (filed 2020-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 4,465 | +14.1% | Form 10-K (filed 2019-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 3,915 | – | Form 10-K (filed 2018-02-20) ↗ |
Breakdown
What makes up consolidated sales rebates and discounts liability
Cite this data
StockData. (2026). Eli Lilly Consolidated sales rebates and discounts liability ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gtn-rebates-liab-cons
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.